
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Income Statement
Earnings Waterfall
Recordati Industria Chimica e Farmaceutica SpA
Revenue
|
2.3B
EUR
|
Cost of Revenue
|
-725.4m
EUR
|
Gross Profit
|
1.5B
EUR
|
Operating Expenses
|
-906.5m
EUR
|
Operating Income
|
637.4m
EUR
|
Other Expenses
|
-214.3m
EUR
|
Net Income
|
423.1m
EUR
|
Income Statement
Recordati Industria Chimica e Farmaceutica SpA
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
982
N/A
|
987
+1%
|
1 003
+2%
|
1 019
+2%
|
1 030
+1%
|
1 048
+2%
|
1 074
+3%
|
1 096
+2%
|
1 126
+3%
|
1 154
+3%
|
1 194
+3%
|
1 217
+2%
|
1 255
+3%
|
1 288
+3%
|
1 313
+2%
|
1 333
+2%
|
1 338
+0%
|
1 352
+1%
|
1 369
+1%
|
1 399
+2%
|
1 439
+3%
|
1 482
+3%
|
1 528
+3%
|
1 499
-2%
|
1 475
-2%
|
1 449
-2%
|
1 404
-3%
|
1 460
+4%
|
1 511
+4%
|
1 580
+5%
|
1 615
+2%
|
1 702
+5%
|
1 801
+6%
|
1 853
+3%
|
1 985
+7%
|
2 005
+1%
|
2 032
+1%
|
2 082
+2%
|
2 139
+3%
|
2 224
+4%
|
2 269
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(330)
|
(327)
|
(328)
|
(328)
|
(334)
|
(335)
|
(341)
|
(344)
|
(351)
|
(361)
|
(373)
|
(377)
|
(381)
|
(383)
|
(386)
|
(389)
|
(391)
|
(396)
|
(403)
|
(416)
|
(429)
|
(437)
|
(446)
|
(425)
|
(416)
|
(407)
|
(385)
|
(401)
|
(412)
|
(428)
|
(439)
|
(490)
|
(538)
|
(567)
|
(615)
|
(611)
|
(634)
|
(660)
|
(688)
|
(732)
|
(725)
|
|
Gross Profit |
652
N/A
|
660
+1%
|
674
+2%
|
691
+2%
|
696
+1%
|
712
+2%
|
734
+3%
|
753
+3%
|
775
+3%
|
793
+2%
|
821
+3%
|
840
+2%
|
874
+4%
|
905
+4%
|
926
+2%
|
944
+2%
|
946
+0%
|
957
+1%
|
966
+1%
|
984
+2%
|
1 011
+3%
|
1 045
+3%
|
1 082
+4%
|
1 073
-1%
|
1 059
-1%
|
1 042
-2%
|
1 019
-2%
|
1 058
+4%
|
1 100
+4%
|
1 152
+5%
|
1 175
+2%
|
1 212
+3%
|
1 264
+4%
|
1 287
+2%
|
1 370
+7%
|
1 394
+2%
|
1 398
+0%
|
1 423
+2%
|
1 450
+2%
|
1 492
+3%
|
1 544
+3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(419)
|
(425)
|
(432)
|
(433)
|
(429)
|
(430)
|
(434)
|
(438)
|
(445)
|
(453)
|
(464)
|
(474)
|
(487)
|
(497)
|
(507)
|
(509)
|
(511)
|
(511)
|
(518)
|
(531)
|
(552)
|
(579)
|
(592)
|
(585)
|
(578)
|
(568)
|
(569)
|
(597)
|
(619)
|
(648)
|
(658)
|
(700)
|
(746)
|
(792)
|
(841)
|
(843)
|
(849)
|
(855)
|
(868)
|
(896)
|
(906)
|
|
Selling, General & Administrative |
(338)
|
(340)
|
(344)
|
(349)
|
(349)
|
(352)
|
(355)
|
(357)
|
(363)
|
(369)
|
(379)
|
(385)
|
(391)
|
(396)
|
(399)
|
(400)
|
(400)
|
(401)
|
(405)
|
(414)
|
(428)
|
(446)
|
(452)
|
(438)
|
(431)
|
(422)
|
(417)
|
(442)
|
(459)
|
(481)
|
(489)
|
(517)
|
(546)
|
(572)
|
(601)
|
(601)
|
(600)
|
(601)
|
(607)
|
(627)
|
(633)
|
|
Research & Development |
(81)
|
(85)
|
(84)
|
(83)
|
(79)
|
(77)
|
(79)
|
(81)
|
(82)
|
(84)
|
(85)
|
(89)
|
(96)
|
(100)
|
(105)
|
(107)
|
(108)
|
(67)
|
(111)
|
(116)
|
(122)
|
(77)
|
(135)
|
(141)
|
(144)
|
(146)
|
(113)
|
(116)
|
(120)
|
(166)
|
(168)
|
(184)
|
(202)
|
(220)
|
(237)
|
(240)
|
(247)
|
(256)
|
(263)
|
(276)
|
(278)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
(4)
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(2)
|
(2)
|
0
|
(2)
|
(1)
|
(3)
|
(4)
|
(5)
|
(6)
|
(3)
|
0
|
(39)
|
(39)
|
(41)
|
(1)
|
(1)
|
1
|
2
|
0
|
(3)
|
(2)
|
(3)
|
2
|
2
|
7
|
5
|
|
Operating Income |
233
N/A
|
236
+1%
|
242
+3%
|
258
+6%
|
267
+4%
|
282
+6%
|
300
+6%
|
316
+5%
|
330
+5%
|
340
+3%
|
357
+5%
|
366
+3%
|
388
+6%
|
409
+5%
|
420
+3%
|
435
+4%
|
436
+0%
|
446
+2%
|
448
+0%
|
453
+1%
|
459
+1%
|
466
+1%
|
490
+5%
|
488
0%
|
481
-1%
|
474
-1%
|
450
-5%
|
461
+2%
|
481
+4%
|
505
+5%
|
517
+3%
|
512
-1%
|
518
+1%
|
495
-4%
|
530
+7%
|
551
+4%
|
549
0%
|
568
+4%
|
582
+3%
|
596
+2%
|
637
+7%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(17)
|
(16)
|
(16)
|
(15)
|
(13)
|
(13)
|
(12)
|
(11)
|
(11)
|
(10)
|
(9)
|
(11)
|
(13)
|
(17)
|
(20)
|
(19)
|
(19)
|
(18)
|
(17)
|
(20)
|
(20)
|
(21)
|
(20)
|
(17)
|
(16)
|
(13)
|
(19)
|
(21)
|
(24)
|
(27)
|
(25)
|
(45)
|
(45)
|
(40)
|
(47)
|
(32)
|
(50)
|
(68)
|
(77)
|
(88)
|
(76)
|
|
Non-Reccuring Items |
(5)
|
(5)
|
0
|
(3)
|
(4)
|
(4)
|
(5)
|
(12)
|
(12)
|
(13)
|
(12)
|
(6)
|
(5)
|
(2)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(0)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(14)
|
(21)
|
(44)
|
(50)
|
(53)
|
(46)
|
(23)
|
(17)
|
(8)
|
(13)
|
(13)
|
(18)
|
|
Total Other Income |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(6)
|
(6)
|
(7)
|
(7)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
210
N/A
|
215
+2%
|
226
+5%
|
239
+5%
|
250
+5%
|
265
+6%
|
283
+7%
|
293
+3%
|
306
+5%
|
317
+4%
|
335
+6%
|
349
+4%
|
369
+6%
|
389
+5%
|
399
+3%
|
416
+4%
|
417
+0%
|
418
+0%
|
424
+2%
|
426
+0%
|
432
+1%
|
444
+3%
|
468
+5%
|
467
0%
|
459
-2%
|
456
-1%
|
426
-6%
|
437
+2%
|
454
+4%
|
463
+2%
|
472
+2%
|
422
-11%
|
422
+0%
|
401
-5%
|
437
+9%
|
496
+14%
|
481
-3%
|
491
+2%
|
492
+0%
|
494
+0%
|
543
+10%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(54)
|
(54)
|
(56)
|
(57)
|
(61)
|
(67)
|
(71)
|
(75)
|
(78)
|
(80)
|
(85)
|
(88)
|
(94)
|
(100)
|
(102)
|
(110)
|
(110)
|
(106)
|
(106)
|
(104)
|
(104)
|
(75)
|
(80)
|
(75)
|
(70)
|
(101)
|
(92)
|
(72)
|
(76)
|
(77)
|
(79)
|
(92)
|
(91)
|
(89)
|
(97)
|
(108)
|
(106)
|
(102)
|
(103)
|
(107)
|
(120)
|
|
Income from Continuing Operations |
156
|
161
|
171
|
182
|
190
|
199
|
212
|
218
|
229
|
237
|
250
|
262
|
275
|
289
|
297
|
306
|
307
|
312
|
318
|
323
|
328
|
369
|
388
|
392
|
389
|
355
|
334
|
365
|
377
|
386
|
393
|
330
|
331
|
312
|
340
|
389
|
375
|
389
|
389
|
387
|
423
|
|
Income to Minority Interest |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
156
N/A
|
161
+3%
|
171
+6%
|
182
+6%
|
190
+5%
|
199
+5%
|
212
+7%
|
218
+3%
|
229
+5%
|
237
+4%
|
250
+5%
|
262
+5%
|
275
+5%
|
289
+5%
|
297
+3%
|
306
+3%
|
307
+0%
|
312
+2%
|
318
+2%
|
322
+1%
|
328
+2%
|
369
+12%
|
388
+5%
|
391
+1%
|
389
-1%
|
355
-9%
|
334
-6%
|
365
+9%
|
377
+3%
|
386
+2%
|
393
+2%
|
330
-16%
|
331
+0%
|
312
-6%
|
340
+9%
|
389
+14%
|
375
-3%
|
389
+4%
|
389
0%
|
387
0%
|
423
+9%
|
|
EPS (Diluted) |
0.7
N/A
|
0.77
+10%
|
0.81
+5%
|
0.86
+6%
|
0.92
+7%
|
0.95
+3%
|
1.02
+7%
|
1.04
+2%
|
1.09
+5%
|
1.14
+5%
|
1.2
+5%
|
1.26
+5%
|
1.32
+5%
|
1.38
+5%
|
1.42
+3%
|
1.46
+3%
|
1.46
N/A
|
1.49
+2%
|
1.52
+2%
|
1.54
+1%
|
1.57
+2%
|
1.76
+12%
|
1.44
-18%
|
1.9
+32%
|
1.86
-2%
|
1.7
-9%
|
1.6
-6%
|
1.75
+9%
|
1.8
+3%
|
1.85
+3%
|
1.88
+2%
|
1.58
-16%
|
1.59
+1%
|
1.52
-4%
|
1.64
+8%
|
1.88
+15%
|
1.82
-3%
|
1.89
+4%
|
1.58
-16%
|
1.87
+18%
|
2.05
+10%
|